Radiation Absorbed Dose to the Basal Ganglia from Dopamine Transporter Radioligand 18 F-FPCIT
Our previous dosimetry studies have demonstrated that for dopaminergic radiotracers, 18 F-FDOPA and 18 F-FPCIT, the urinary bladder is the critical organ. As these tracers accumulate in the basal ganglia (BG) with high affinity and long residence times, radiation dose to the BG may become significan...
Saved in:
Published in | BioMed research international Vol. 2014; pp. 1 - 5 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Hindawi Limited
01.01.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Our previous dosimetry studies have demonstrated that for dopaminergic radiotracers,
18
F-FDOPA and
18
F-FPCIT, the urinary bladder is the critical organ. As these tracers accumulate in the basal ganglia (BG) with high affinity and long residence times, radiation dose to the BG may become significant, especially in normal control subjects. We have performed dynamic PET measurements using
18
F-FPCIT in 16 normal adult subjects to determine if in fact the BG, although not a whole organ, but a well-defined substructure, receives the highest dose. Regions of interest were drawn over left and right BG structures. Resultant time-activity curves were generated and used to determine residence times for dosimetry calculations.
S
-factors were computed using the MIRDOSE3 nodule model for each caudate and putamen. For
18
F-FPCIT, BG dose ranged from 0.029 to 0.069 mGy/MBq. In half of all subjects, BG dose exceeded 85% of the published critical organ (bladder) dose, and in three of those, the BG dose exceeded that for the bladder. The BG can become the dose-limiting organ in studies using dopamine transporter ligands. For some normal subjects studied with F-18 or long half-life radionuclide, the BG may exceed bladder dose and become the critical structure. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2314-6133 2314-6141 |
DOI: | 10.1155/2014/498072 |